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Dbetween the aorta and the right ventricle caused by injury to
the membranous septum while performing subcommissural
annuloplasty. Subcommissural annuloplasty in this region is
thus performed at a higher level to avoid this complication. It
can be performed lower in the fibrous portion of the suban-
nular region to increase coaptation surface of the cusps. One
late AV reoperation occurred in a patient who had under-
gone cusp repair for a type I valve with subcommissural
annuloplasty and presented 6.5 years later with recurrent
cusp prolapse and dilatation of the ventriculoaortic junction.
Surgical inspection revealed dilatation of the muscular
portion of the aortic annulus and migration of the subcom-
missural annuloplasty sutures and resulting prolapse of the
conjoint cusp. This reinforces the idea that the aortic annulus
in these patients can continue to dilate over time, and root re-
placement using the reimplantation technique should be
used aggressively to stabilize the repair.STUDY LIMITATIONS
This is a single-center experience using an approach and
surgical techniques that have evolved over the past decade.
In addition, follow-up echocardiographic information was
not always obtained at Saint Luc Hospital, and thus a number
of quantitative parameters (size of aortic annulus, root, and
aorta) and descriptive features of recurrent AI (quantity, jet
origin, and direction) were not systematically available
and may have provided greater insight into the mechanisms
of repair failures.CONCLUSIONS
Repair of the BAV needs to address the pathology of the
cusp and the functional aortic annulus and be tailored to the
specific anatomy of the valve. Repair of regurgitant bicuspid
valves is feasible and provides excellent freedom from
valve-related complications. Freedom from reoperation
and recurrent insufficiency are acceptable at midterm
follow-up. Longer follow-up studies are required to deter-
mine the role of repair in the treatment of BAV insufficiency
in young patients.References
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Dr Hartzell Schaff (Rochester, Minn). Congratulations to Drs
Boodhwani and El Khoury and their associates for a beautiful pre-
sentation, which is useful to us because it shows the spectrum of
operations in patients with BAV disease and is notable for the
very low mortality.
The problem with the article in regard to application to clinical
practice is that most patients with BAV disease present in 1 of 3
ways in terms of consideration of repair. Those are the patients
with severe AV regurgitation and indication for operation is severe
AR. Also, patients may have an enlarged aorta with only moderate
AR. And a few patients present with both. I think it is important toery c August 2010
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Dlook at the results of valve repair in each of those categories. So the
first question is, have you analyzed the outcome in regard to need
for reoperation according to the severity of the AV regurgitation?
Dr Boodhwani. That is a very important question, and we have
analyzed our data with regard to operative indication. I can show
you a slide with regard to this. Essentially, we did not find any dif-
ference among the 3 modes of presentation and the long-term out-
come with regard to recurrent AI or to AV reoperation, and we can
view that data here.
(Slide) This is freedom fromAV reoperation in patients who had
AI only, AI plus dilatation, or dilatation only, and there is really no
significant difference to speak of. Similarly, recurrent AI is similar
between groups as well.
Dr Schaff. And knowing that you have these good results with
repair of severe aortic regurgitation, has it changed your threshold
for advising operation as it has, for example, with mitral regurgita-
tion and the ability to repair the valve rather than replace it?
Dr Boodhwani. In fact, one of the common findings in the entire
cohort of AV repair that we have accumulated over the years is that
patients with greater dilatation of the left ventricular cavity have an
increased risk of recurrent AI. So the longer you wait in terms of
referring these patients to surgery, if they are to undergo repair,
they will have a poorer longer-term result with the repair, and
that may be an impetus to refer these patients for repair earlier. Hav-
ing said that, there aren’t convincing data in the literature to date to
make such a recommendation, but these are some of the data that
we are analyzing in our cohort.
Dr Schaff. One of the things that I noticed in your presentation
and article that differs from our experience is the frequency with
which you use aortic root replacement. We do see patients with di-
latation of the sinus portion of the aorta who have BAV, but, more
commonly, the patients at our clinic receive replacement of the as-
cending aorta with a supracoronary graft. What accounts for the
high frequency of replacement of the sinus portion of the aorta in
this series?
Dr Boodhwani. The first comment would be that this approach
has evolved over 13 years of experience, and over that time period
we have become more aggressive with root replacement, because
we have observed that patients in whom the aortic root is stabilized
with subcommissural annuloplasty alone tend to come back with
some AI over the long term. So our threshold has decreased over
time.
The second issue is that the criteria for root replacement, as you
mentioned, is not size alone. Often you find a root that is 4 cm in
size, but when you examine the aortic wall, particularly above
the anterior cusp below the right coronary artery insertion, it is
very fine. It can be occasionally translucent, and you can see the
left ventricular muscle through it, and in those cases we opt to
replace the root.
Dr Schaff. If you have a retracted cusp with scarring or enough
calcification that you have to use pericardium, would you do that
now or would you just replace the valve?
Dr Boodhwani. I think that has to take into account the broader
context of the patient. If the patient is very interested in avoiding
Coumadin and it is a young patient, we would be more aggressive
with repair techniques. On the other hand, if it is an older patient
who would be fine with a bioprosthetic valve, in those difficult
cases we may opt for replacement.The Journal of Thoracic and CaDr Jason Sperling (Ridgewood, NJ). Nothing to disclose.
Thank you for that fantastic presentation. I wanted to make a com-
parison and perhaps a suggestion. These results are fantastic, and I
hope we continue to build on them.
In mitral valve repair, when we do leaflet-based repairs, we still
do an annuloplasty to protect that repair in the future so that annular
changes don’t ruin the nice leaflet repair. You are doing these leaf-
let-based repairs with what you are calling a subcommissural annu-
loplasty, but perhaps a mechanism of failure is that your annulus,
your true annulus, the ventriculoaortic junction, is changing over
time, and we noticed that in AI annuli, these are usually pretty
big annuli to begin with and perhaps there is a predisposition for
further dilatation over time. Why not, just as in a valve-sparing
root type dissection, simply do a real aortic annuloplasty (which
is possible)? You just cut your Dacron graft, do it over a Hegar
dilator, and fix it in a particular configuration just like we do for
a mitral valve. Do you think that that might enhance the durability
of these repairs? Obviously, we want these repairs to be durable
over time.
Dr Boodhwani. That is a great question. That is something that
we have thought about a lot over the course of the years and over
the course of our experience. To be honest, there isn’t a particular
device or technique that has currently been described to facilitate
a complete annuloplasty of the ventriculoaortic junction. Effec-
tively, that is performed using the aortic root reimplantation proce-
dure, and that is part of the reason why we think we observed better
results in that cohort. Earlier in our experience, and even occasion-
ally now, we will use subcommissural annuloplasty with the same
purpose, to try and stabilize the ventriculoaortic junction, but these
are not as stable over time.
I think there is a need for developing a method for annuloplasty
of the ventriculoaortic junction without having to replace the entire
root. If you put a Dacron graft around the root and maintain the na-
tive root in place, you are potentially at risk for inducing more cusp
prolapse because of the extensive amount of tissue that is within
that Dacron graft.
Dr Sperling. I think it is possible to do an annuloplasty without
actually replacing the sinus tissue with and extensive surgical dis-
section of the root down to the ventriculo-annular junction, again,
just with a very small ring or a piece of Dacron over a dilator. I think
it is something to consider.
Dr Boodhwani. Again, the anatomic limitations that prevent us
are at the level of the membranous septum and the level of what
would normally be a left–right commissure. We don’t always dissect
all the way down to the level of the ventriculoaortic junction. To
place an annuloplasty device at that level, it may not be symmetric.
But I agree with you that this concept needs to be further developed.
Dr Antonio Laudito (Wichita, Kan). My question is regarding
the ascending aorta. You were talking about criteria of resection,
but at the end you didn’t really point out what size, considering
your large experience, you are pushing your replacement. We
know that with the bicuspid valve-ascending aorta, in case of dila-
tation, we are more aggressive than for the regular aneurysm. In
your experience, how far down in size have you been going?
Dr Boodhwani. If a patient is presenting for isolated aortic di-
latation, our threshold is still the that recommended by the Ameri-
can Heart Association and European Society of 5 cm, if that is the
only pathology they have. However, if the patients are presentingrdiovascular Surgery c Volume 140, Number 2 283
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Dwith AI and aortic dilatation, then there is the dual indication for re-
ferral to surgery. In those cases we are more aggressive. And, as I
mentioned in the algorithm, anyone above 4.5 will definitely get
a root replacement, whereas below 4.5, it is a judgment call based
on the quality of the tissue.
Dr Robert Dion (Genk, Belgium). I am proud of what my team
in Brussels has developed in this field. I have a short clinical com-
ment related to my initial experience. When you have a type I with
a common prolapsing leaflet, the first move would be to adapt this
prolapsing leaflet, with or without eliminating the raphe, to the
height of the other one. But I think we should reinforce the impor-
tance of first checking this other one, which should not be prolaps-
ing at all! How often does it happen in your experience that you
have to correct not only the obviously prolapsing one but also the284 The Journal of Thoracic and Cardiovascular Surgfalsely normal one? I think it is an important point for people start-
ing their experience in this field.
Dr Boodhwani. Excellent comment. In fact, an intervention on
the nonconjoint cusp is required in a good proportion of patients
(30%–40%), and the reason for that is 2-fold. One is that the non-
conjoint cusp may in fact be prolapsing in addition to the conjoint
cusp. Second, when you perform a root replacement procedure and
reduce the ventriculoaortic junction diameter, you may induce pro-
lapse of that leaflet. For both of those reasons, after any work has
been done on the raphe or root, we examine both leaflets to make
sure that the height of coaptation is at the midlevel of the sinuses
of Valsalva, which is the physiologic valve coaptation level, and
that both cusps are coapting at the same level, and those 2 are crit-
ical points for long-term function of this valve.ery c August 2010
